Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 404-910-2 | CAS number: 164578-14-7 PIGMENT ADDITIV C
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Oct 1989
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- Adopted 1983
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- 2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide
- EC Number:
- 404-910-2
- EC Name:
- 2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide
- Cas Number:
- 164578-14-7
- Molecular formula:
- C25H31N7O4
- IUPAC Name:
- N-[3-(diethylamino)propyl]-4-[(1E)-2-{2-oxo-1-[(2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)carbamoyl]propyl}diazen-1-yl]benzamide
- Test material form:
- solid: bulk
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hoechst AG, Kastengrund, SPF breeding colony
- Age at study initiation: 7 weeks
- Weight at study initiation:
- males: 29.6 g (23-34 g)
- females: 23.8 g (21-27 g)
- Housing: in fully air-conditioned rooms in Macrolon cages type 3, on softwood granulate in groups of 5 animals
- Diet (e.g. ad libitum): rat/mice diet Altromin 1324 (Altromin GmbH, Lage/Lippe), ad libitum
- Water (e.g. ad libitum): tap water in plastic bottles, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/-2°C
- Humidity (%): 55+/-10%
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES:
From: 16. Oct. To: 19. Oct. 1989
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: sesame oil
- Justification for choice of solvent/vehicle: homogenity of test item in suspension
- Concentration of test material in vehicle: 25% (w/v)
- Amount of vehicle (if gavage or dermal): 20 mL/kg bw diveded into two equal parts of 10 mL/kg bw, administered within 2 h - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Test compound dilutions were prepared fresh each day. 6250 mg of test substance were weight in a beaker, mixed with sesmae oil, washed out in a 25 mL flasked and topped up to the calibration mark. A suspension was formed. - Frequency of treatment:
- two equal portions within 2 h
- Post exposure period:
- animals were killed 24, 48 or 72 h after application (sampling of bone marrow)
Doses / concentrations
- Dose / conc.:
- 5 000 mg/kg bw/day (actual dose received)
- Remarks:
- based on preliminary study for acute toxicity
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Endoxan (cyclophosphamid)
- Justification for choice of positive control(s):
- Route of administration: gavage
- Doses / concentrations: 50 mg/kg bw
Examinations
- Tissues and cell types examined:
- immature erythrocytes of the bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Based on preliminary test for acute toxicity
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
one oral application (gavage; two equal volumes within 2 h)
sampling times: 24, 48 and 72 h adfter application
DETAILS OF SLIDE PREPARATION:
For each animal approx. 3 mL FCS was poured into a centrifuge tube. Both femora were removed and the bones freed of muscle tissue. The proximal ends of the femora were opened and the bone marrow flushed into the centrifuge tube. A suspension was formed. The mixture was then centrifuged for 5 min at 1200 rpm and almost all the supernatant discarded. One drop of the thoroughly mixed sediment was semared on a cleaned slide, and air-dried for approx. 24 h.
Staining procedure.
5 min methanol, 3 min May-Grünwalds solution, 2 min May-Grünwalds solution diluted 1:1 with distilled water, rinsing with dstilled water, 10 min staining with Giemsa, rinsing with distilled water, coating with Entellan
METHOD OF ANALYSIS:
1000 polychromatic erythrocytes were counted for each animal. The number of cells with micronuclei was recorded. As a control measure 1000 mature erythrocytes were also counted ans examined for micronuclei. In addtition, the ratio of polychromatic to normochromatic erythrocytes was determined.
- Evaluation criteria:
- according to OECD guideline 474, 1983
- Statistics:
- according to Wilcoxon (paired, one-sided increase)
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- All animals survived after application and showed no signs of toxicity.
The incidence of micronucleated polychromatic erythrocytes in the dose dose groups of the test item was within the normal range of the negative control groups. No statistically significant increase of micronucleated plychromatic erythrocytes has been observed. The number of normchromatic erythrocytes with micronulcei did not differ significantly from the values of the simulatneous control animals for each of the three killing times investigated. The ratio of polychromatic erythrocytes to normocytes remained essentially unaffected by the test comound.
Cyclophosphamid induced a marked and statistically significant increase of the number of polychromatic erythrocytes with micronuclei in both males and females indicating the sensitivity to the test system.
Applicant's summary and conclusion
- Conclusions:
- The results of this in vivo MNT in mice indicate that, under the conditions of the present study, the test substance is not mutagnic in the micronucleus test.
- Executive summary:
The test item was tested in the in vivo MNT. It was administered orally by gavage to male and female mice in doses of 0 and 5000 mg/kg bw.
The high dose was chosen since a preliminary study had shown it to be the maximum appicable dose.
The test compound was given in two equal parts within two hours and according to the test procedure the animals were killed 24, 48 or 72 h after administration. Cyclophosphamid was used as positive control substance and administered orally at a dose of 50 mg/kg bw. The incidence of micronucleated polychromatic erythrocytes of the animals treated with the test item was within the normal range of the negative control. The number of normochrmatic erythrocytes containing micronuclei was not increased. The ratio of polychromatic/normochromatic erythrocytes in both male and female animals remained unaffected by the treatment with the test substance and was statistically not different from the control values. Cyclophosphamid induced in both males and females a marked statistically significant increase in the number of polychromatic cells with micronuclei, indicating the sensitivity of the system. The ratio of polychromatic erythrocytes to normocytes showed a difference to the negative control values.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.